Centre Hospitalier Universitaire - CHU Limoges
Limoges, 87042, France
Location status: Recruiting
NCT Number: NCT06972953
The aim of the study is to confirm the safe and successful use of the SmartGUIDE guidewire, when used in neuro interventions. The performance of the SmartGUIDE guidewire in terms of safe and successful navigation within the neurovasculature will be compared to standard of care guidewire on the market.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Limoges, 87042, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
SmartGUIDE is a deflectable guidewire for use in interventional procedures in the neurovasculature and the peripheral vasculature. It can be used to selectively introduce and position catheters and other interventional devices within the peripheral and neurovasculature. The device is a steerable guidewire with a deflectable tip. This allows adjusting the shape of the tip, dynamically, while the physician navigates the device in the patient's arterial and venous circulatory system.
The control device is any standard of care guidewire as per hospital routine indicated for neuro-interventional procedures.
Time frame: During index procedure
Intra-procedural technical success defined as successful navigation of device to the target vessel without need for shaping by hand, removal or exchange.
Time frame: During index procedure
Usability data (shape retention, pushability, trackability, navigability, support, proximal access complexity) collected through questionnaire.
Time frame: During index procedure
Procedural times (duration of tip reshaping, duration of access to target, duration of fluoroscopic exposition).
Time frame: During index procedure and up to 48 hours post procedure
Occurrence of adverse events.
Time frame: During index procedure
Occurrence of intra-procedural device deficiencies.
Contact information is provided by the study sponsor or research team.
Artiria Medical
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06972966
Unruptured Cerebral Aneurysm
Warsaw, Poland
View Trial DetailsNCT04155606
Aneurysm, Brain Diseases
Edmonton, Alberta, Canada
View Trial DetailsNCT06766422
Aneurysm, Artificial Intelligence (AI)
Shanghai, China
View Trial DetailsNCT03936647
Aneurysm, Brain Aneurysm
Edmonton, Alberta, Canada
View Trial Details